The Australian Cell Therapy Society (ACTS) is Australia’s peak body representing people working and studying in, or interested in, the field of cellular therapies.
Australia is a world leader in the research and development of cellular therapies, which offer promise and great potential for treating a striking breadth of injury and disease.
In addition to it’s broader objectives in the field, ACTS was established to facilitate and monitor compliance with requirements of the Code of Practice for Autologous Cell-Based interventions.
ACTS is dedicated to the professional growth and development of its members with particular emphasis on autologous cell-based interventions (ACBIs), which involve the collection, ex vivo manipulation and administration of a patient’s own cells, which offer promise and great potential for treating a striking breadth of injury and disease.
Objectives of ACTS
- To promote the welfare of patients
- To promote and develop the ACTS ‘Code of Practice’
- To promote and protect the interests of its members in Australia
- To provide a forum for discussing professional use of ACBI’s.
- To assist the membership in the professional effective execution of their duties.
- To consider, originate and promote improvements or amendments to the law as it relates to the medical profession, the practice of medicine or to the medical or allied sciences for ACBI’s
- To develop and advance the public health in the area of ACBI’s
- To foster and sustain consultation and communication within the medical and scientific profession for ACBI use.
We welcome membership from individuals from all fields of cell therapy and related disciplines.
Please select the Membership tab for information on membership and becoming a signatory to the Code of Practice.
This website will be constantly updated with information of importance and relevance to members and stakeholders.